|
Video: What is a Stock Split?
|
|
Cumberland Pharmaceuticals is a pharmaceutical company that acquires, develops and commercializes prescription pharmaceutical products. Co.'s portfolio of brands includes: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for oral solution, for the treatment of constipation; Omeclamox-Pak®, (omeprazole, clarithromycin, amoxicillin) oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia. According to our Cumberland Pharmaceuticals stock split history records, Cumberland Pharmaceuticals has had 0 splits. | |
|
Cumberland Pharmaceuticals (CPIX) has 0 splits in our Cumberland Pharmaceuticals stock split history database.
Looking at the Cumberland Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cumberland Pharmaceuticals shares, starting with a $10,000 purchase of CPIX, presented on a split-history-adjusted basis factoring in the complete Cumberland Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$4.52 |
|
End price/share: |
$1.65 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-63.50% |
|
Average Annual Total Return: |
-9.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,649.93 |
|
Years: |
10.00 |
|
|
|
|
|